The Claim
In non-diabetic adults with overweight or obesity, administration of once-weekly semaglutide at a dose of 2.4 mg over 68 weeks results in a mean reduction of fat mass by 13.2 kg and visceral fat by 0.25 kg, with a relative increase in lean body mass proportion despite an absolute decrease, indicating a preferential loss of fat over lean tissue.
What the research says
Challenges is higher
Challenge is ahead, but a single strong supporting study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
If you're an adult with extra weight but don't have diabetes, taking a weekly 2.4 mg shot of semaglutide for about a year and a half can help you lose around 13 kg of fat, including some deep belly fat, while mostly keeping your muscle — even though you might lose a little muscle too, the fat loss is much bigger.
See the scientific wording
In non-diabetic adults with overweight or obesity, once-weekly semaglutide at 2.4 mg leads to a mean fat mass reduction of 13.2 kg and visceral fat reduction of 0.25 kg over 68 weeks, with a relative increase in lean body mass proportion despite absolute loss, indicating preferential fat loss.
What the research says
1 studyStudy: Once-Weekly Semaglutide in Adults with Overweight or Obesity.
The study tested the same drug and found big weight loss, but it didn’t measure how much was fat or muscle, so we can’t say if the specific numbers in the claim are right.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.